- 专利标题： 4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZINE AS MODULATORS OF GPR139
-
申请号： US15382490申请日： 2016-12-16
-
公开(公告)号： US20170095480A1公开(公告)日： 2017-04-06
- 发明人: Stephen Hitchcock , Betty Lam , Holger Monenschein , Holly Reichard
- 申请人： Takeda Pharmaceutical Company Limited
- 申请人地址： US CA San Diego
- 专利权人： TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 当前专利权人： TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 当前专利权人地址： US CA San Diego
- 主分类号： A61K31/53
- IPC分类号： A61K31/53
摘要：
The present invention provides a method for treating a disease, disorder or condition associated with GPR139 using compounds of formula 1: which are agonists of GPR139, certain compounds encompassed by formula 1, pharmaceutical compositions thereof, processes for making the compounds, and intermediates thereof.
公开/授权文献
信息查询
